Articles
Volume 12 Supplement 2
Advanced breast cancer therapy
Reviews
Edited by Jenny Chang
Publication of this supplement has been sponsored by Bristol Myers Squibb Company. Translation services and administrative support was provided to the authors by Thomson Reuters, Healthcare and Science.
|
Present and future evolution of advanced breast cancer therapy Ricardo H Álvarez Breast Cancer Research 2010, 12(Suppl 2):S1 (22 October 2010) |
|
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone Edgardo Rivera, Henry Gomez Breast Cancer Research 2010, 12(Suppl 2):S2 (22 October 2010) |
|
Reinaldo D Chacón, María V Costanzo Breast Cancer Research 2010, 12(Suppl 2):S3 (22 October 2010) |

